Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016–2018
References
- Government of India.
Key Indicators of Social Consumption in India – Health. NSS 75th Round. July 2017–June 2018 . Ministry of Statistics and Programme Implementation. Kolkata, India: National Sample Survey Office, 2019.http://mospi.nic.in/sites/default/files/publication_reports/KI_Health_75th_Final.pdf . - Pathni AK, Sahoo SK, Moran AE, Cohn J, Bhatia S, Maheshwari N, et al. Unmet need for hypertension treatment in India: Evidence from hypertension drugs market data. Glob Heart. 2021 Apr 23; 16(1): 26. DOI: 10.5334/gh.973
- Shah SN, Munjal YP, Kamath SA, Wander GS, Mehta N, Mukherjee S, et al. Indian guidelines on hypertension-IV (2019). J Hum Hypertens. 2020; 34(11): 745–758. DOI: 10.1038/s41371-020-0349-x
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311(5): 507–520. DOI: 10.1001/jama.2013.284427
- Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338(7705): 1245. DOI: 10.1136/bmj.b1665
- Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017 Jan 20; 1(1):
CD002003 . DOI: 10.1002/14651858.CD002003.pub5 - DiPette DJ, Skeete J, Ridley E, Campbell NRC, Lopez-Jaramillo P, Kishore SP, et al. Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications. J Clin Hypertens (Greenwich). 2019; 21(1): 4–15. DOI: 10.1111/jch.13426
- Government of India. Ministry of Health and Family Welfare. National List of Essential Medicines. 2015.
https://www.nhp.gov.in/NHPfiles/NLEM%2C%202015.pdf . - World Health Organization.
Model List of Essential Medicines, 21st List, 2019 . Geneva: World Health Organization; 2019.https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf . - Bureau of Pharma PSUs of India (BPPI), Government of India. Product and MRP list. 2020.
http://janaushadhi.gov.in/ProductList.aspx (accessed 10 Dec 2020). - Negi S, Neupane D, Sahoo SK, Mahajan T, Swaroop K, Moran AE, et al. Prices of combination medicines and single-molecule anti-hypertensive medicines in India’s private health care sector. J Clin Hypertens (Greenwich). 2021 Apr; 23(4): 738–743. DOI: 10.1111/jch.14143
- DiPette DJ, Goughnour K, Zuniga E, Skeete J, Ridley E, Angell S, et al. Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative. J Clin Hypertens (Greenwich). 2020 Dec; 22(12): 2285–2295. DOI: 10.1111/jch.14072
- Valdés González Y, Campbell NRC, Pons Barrera E, Calderón Martínez M, Pérez Carrera A, Morales Rigau JM, et al. Implementation of a community-based hypertension control program in Matanzas, Cuba. J Clin Hypertens (Greenwich). 2020 Feb; 22(2): 142–149. DOI: 10.1111/jch.13814
DOI: https://doi.org/10.5334/gh.999 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jan 30, 2021
Accepted on: Jul 6, 2021
Published on: Aug 2, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2021 Swagata Kumar Sahoo, Anupam Khungar Pathni, Ashish Krishna, Andrew E. Moran, Jennifer Cohn, Sanchit Bhatia, Nilesh Maheshwari, Bhawna Sharma, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.